Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Tanya Bogle

Family Medicine Lutz, FL Medical Doctor

NPI 1316380041 CMS profile 3294478

17645 Jamestown Way, Lutz, FL 33558

Open in the dashboard

General payments

$2,913

110 records reported · program years 2019–2025

Research payments

$26,582

Paid to them · 13 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$3,363,509 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Tanya Bogle of Lutz, FL is reported in the CMS Open Payments database as having received $2,913 across 110 general payments and $26,582 in research payments paid to them. Separately, studies naming them as principal investigator received $3,363,509 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Family Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

10 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $18 1
2023 Research $583 2
2022 General $35 1
2022 Research $2,457 5
2021 General $534 29
2021 Research $1,548 3
2020 General $718 42
2020 Research $19,930 2
2019 General $1,608 37
2019 Research $2,064 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Tanya Bogle
  • Family Medicine median
  • Middle half of Family Medicine
  • National median

In program year 2025, general payments to Tanya Bogle were reported at $18. Among 56,786 Family Medicine profiles paid that year, the median was $155 and the middle half received between $45 and $549.

Show as a table
Year Tanya Bogle Family Medicine median Middle half National median
2019 $1,608 $150 $41–$543 $163
2020 $718 $120 $32–$415 $114
2021 $534 $137 $35–$551 $132
2022 $35 $137 $37–$512 $149
2023 $0 $149 $42–$545 $160
2024 $0 $156 $44–$560 $164
2025 $18 $155 $45–$549 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Eli Lilly and Company $1,345 21 payments
  2. Amgen Inc. $729 45 payments
  3. AstraZeneca Pharmaceuticals LP $213 6 payments
  4. AbbVie, Inc. $101 5 payments
  5. Lilly USA, LLC $67 5 payments
  6. GlaxoSmithKline, LLC. $53 3 payments
  7. Pfizer Inc. $52 5 payments
  8. Nestle HealthCare Nutrition Inc. $51 2 payments
  9. Celgene Corporation $39 2 payments
  10. Merck Sharp & Dohme Corporation $37 2 payments
  11. Other $226 14 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $1,757 103 payments
  2. Travel and Lodging $1,128 5 payments
  3. Education $28 2 payments
Products named General payments · program years 2019–2025
  1. Prolia $300 21 payments
  2. Enbrel Inflammation $179 13 payments
  3. FARXIGA $178 4 payments
  4. Enbrel Inflammation $173 13 payments
  5. Otezla $137 3 payments
  6. EVENITY $124 8 payments
  7. AVSOLA $60 7 payments
  8. Repatha $59 4 payments
  9. AIMOVIG $59 4 payments
  10. Enbrel Inflammation $55 4 payments
  11. Other $777 47 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Eli Lilly and Company $26,582 13 payments

Records

123 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Family Medicine in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record